• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

[123I]β-CIT单光子发射计算机断层扫描(SPECT)显示,处于Hoehn和Yahr I期和II期的未经药物治疗的帕金森病患者纹状体多巴胺转运体出现双侧减少。

Drug-naive patients with Parkinson's disease in Hoehn and Yahr stages I and II show a bilateral decrease in striatal dopamine transporters as revealed by [123I]beta-CIT SPECT.

作者信息

Tissingh G, Bergmans P, Booij J, Winogrodzka A, van Royen E A, Stoof J C, Wolters E C

机构信息

Academisch Ziekenhuis Vrije Universiteit, Department of Neurology, Amsterdam, The Netherlands.

出版信息

J Neurol. 1998 Jan;245(1):14-20. doi: 10.1007/s004150050168.

DOI:10.1007/s004150050168
PMID:9457623
Abstract

Ten healthy subjects and 16 patients with early Parkinson's disease (PD) were examined with single photon emission computed tomography (SPECT) and [123I]beta-CIT, a ligand for the dopamine (DA) transporter. Only drug-naive patients were examined since the expression of and binding to DA transporters may be influenced by dopaminergic medication. The main finding was a significant reduction in [123I]beta-CIT binding in the ipsi- and contralateral striatal regions, especially in the putamen, which showed a mean reduction of 65% of the control mean. Discriminant function analysis of the putaminal [123I]beta-CIT binding measures classified 100% of the cases in the correct group. Disease severity correlated negatively and highly significantly with the binding measures. Tremor ratings did not correlate with the SPECT measures, whereas rigidity, and to a lesser extent bradykinesia, did. Patients with unilateral PD showed a bilateral loss of striatal DA transporters. Our findings indicate that with [123I]beta-CIT SPECT it is possible to diagnose PD in subjects with very mild symptoms and signs. Moreover, finding a bilateral loss of striatal DA transporters in patients with unilateral PD also suggests that it may be possible to identify subjects in the preclinical phase of the disease.

摘要

10名健康受试者和16名早期帕金森病(PD)患者接受了单光子发射计算机断层扫描(SPECT)检查,并使用了[123I]β-CIT,一种多巴胺(DA)转运体的配体。仅对未服用过药物的患者进行了检查,因为多巴胺能药物可能会影响DA转运体的表达和结合。主要发现是同侧和对侧纹状体区域的[123I]β-CIT结合显著减少,尤其是壳核,其平均减少量为对照平均值的65%。对壳核[123I]β-CIT结合测量值进行判别函数分析,将100%的病例正确分类。疾病严重程度与结合测量值呈高度显著的负相关。震颤评分与SPECT测量值无关,而僵直以及程度较轻的运动迟缓则相关。单侧PD患者表现出双侧纹状体DA转运体缺失。我们的研究结果表明,使用[123I]β-CIT SPECT能够在症状和体征非常轻微的受试者中诊断出PD。此外,在单侧PD患者中发现双侧纹状体DA转运体缺失也表明,有可能识别出处于疾病临床前期的受试者。

相似文献

1
Drug-naive patients with Parkinson's disease in Hoehn and Yahr stages I and II show a bilateral decrease in striatal dopamine transporters as revealed by [123I]beta-CIT SPECT.[123I]β-CIT单光子发射计算机断层扫描(SPECT)显示,处于Hoehn和Yahr I期和II期的未经药物治疗的帕金森病患者纹状体多巴胺转运体出现双侧减少。
J Neurol. 1998 Jan;245(1):14-20. doi: 10.1007/s004150050168.
2
Iodine-123-N-omega-fluoropropyl-2beta-carbomethoxy-3beta-(4-iod ophenyl)tropane SPECT in healthy controls and early-stage, drug-naive Parkinson's disease.健康对照者及早期未用药帕金森病患者的碘-123-N-ω-氟丙基-2β-甲氧基羰基-3β-(4-碘苯基)托烷单光子发射计算机断层扫描
J Nucl Med. 1998 Jul;39(7):1143-8.
3
Iodine-123-beta-CIT and iodine-123-FPCIT SPECT measurement of dopamine transporters in healthy subjects and Parkinson's patients.碘-123-β-CIT和碘-123-FPCIT单光子发射计算机断层扫描测量健康受试者和帕金森病患者的多巴胺转运体
J Nucl Med. 1998 Sep;39(9):1500-8.
4
SPECT measurement of iodine-123-beta-CIT binding to dopamine and serotonin transporters in Parkinson's disease: correlation with symptom severity.帕金森病中碘-123-β-CIT与多巴胺和5-羟色胺转运体结合的单光子发射计算机断层扫描测量:与症状严重程度的相关性
Neurol Res. 1999 Apr;21(3):255-61. doi: 10.1080/01616412.1999.11740928.
5
[123I]FP-CIT SPECT shows a pronounced decline of striatal dopamine transporter labelling in early and advanced Parkinson's disease.[123I]FP - CIT单光子发射计算机断层扫描显示,在早期和晚期帕金森病中,纹状体多巴胺转运体标记明显减少。
J Neurol Neurosurg Psychiatry. 1997 Feb;62(2):133-40. doi: 10.1136/jnnp.62.2.133.
6
Test/retest reproducibility of iodine-123-betaCIT SPECT brain measurement of dopamine transporters in Parkinson's patients.帕金森病患者中碘-123-β-CIT单光子发射计算机断层扫描脑多巴胺转运体测量的重测信度
J Nucl Med. 1997 Sep;38(9):1453-9.
7
SPECT-evaluation of the monoamine uptake site ligand [123I](1R)-2-beta-carbomethoxy-3-beta-(4-iodophenyl)-tropane ([123I]beta-CIT) in untreated patients with suspicion of Parkinson disease.对疑似帕金森病的未治疗患者进行单胺摄取位点配体[123I](1R)-2-β-甲氧羰基-3-β-(4-碘苯基)托烷([123I]β-CIT)的单光子发射计算机断层扫描(SPECT)评估。
J Investig Med. 1997 Oct;45(8):448-52.
8
Functional morphometry of the striatum in Parkinson's disease on three-dimensional surface display of 123I-beta-CIT SPECT data.帕金森病纹状体的功能形态计量学研究:基于123I-β-CIT SPECT数据的三维表面显示
J Nucl Med. 1999 Apr;40(4):530-8.
9
Serotonin transporters in the midbrain of Parkinson's disease patients: a study with 123I-beta-CIT SPECT.帕金森病患者中脑的5-羟色胺转运体:一项使用123I-β-CIT单光子发射计算机断层扫描的研究
J Nucl Med. 2003 Jun;44(6):870-6.
10
Imaging of dopamine transporters with iodine-123-FP-CIT SPECT in healthy controls and patients with Parkinson's disease.健康对照者和帕金森病患者中使用碘-123-FP-CIT单光子发射计算机断层扫描成像检测多巴胺转运体
J Nucl Med. 1998 Nov;39(11):1879-84.

引用本文的文献

1
Levodopa treatment: impacts and mechanisms throughout Parkinson's disease progression.左旋多巴治疗:贯穿帕金森病进展过程中的影响及机制。
J Neural Transm (Vienna). 2025 Apr 11. doi: 10.1007/s00702-025-02893-4.
2
Striatal Dopamine Loss in Early Parkinson's Disease: Systematic Review and Novel Analysis of Dopamine Transporter Imaging.早期帕金森病纹状体多巴胺缺失:多巴胺转运体成像的系统评价与新分析
Mov Disord Clin Pract. 2023 Feb 17;10(4):539-546. doi: 10.1002/mdc3.13687. eCollection 2023 Apr.
3
Mapping microstructural gradients of the human striatum in normal aging and Parkinson's disease.
绘制正常衰老和帕金森病患者纹状体的微观结构梯度图。
Sci Adv. 2022 Jul 15;8(28):eabm1971. doi: 10.1126/sciadv.abm1971.
4
Dopamine Transporter Imaging, Current Status of a Potential Biomarker: A Comprehensive Review.多巴胺转运体显像:一个潜在生物标志物的现状综述。
Int J Mol Sci. 2021 Oct 18;22(20):11234. doi: 10.3390/ijms222011234.
5
Impaired reach-to-grasp kinematics in parkinsonian patients relates to dopamine-dependent, subthalamic beta bursts.帕金森病患者抓握动作的运动学受损与多巴胺依赖的丘脑底核β波爆发有关。
NPJ Parkinsons Dis. 2021 Jun 29;7(1):53. doi: 10.1038/s41531-021-00187-6.
6
Parkinson's Disease-Related Motor and Nonmotor Symptoms in the Lancaster Amish.兰开斯特亚米希人群中的帕金森病相关运动和非运动症状。
Neuroepidemiology. 2020;54(5):392-397. doi: 10.1159/000509394. Epub 2020 Jul 31.
7
The longitudinal associations between cognition, mood and striatal dopaminergic binding in Parkinson's Disease.帕金森病患者认知、情绪与纹状体多巴胺能结合的纵向关联。
Neuropsychol Dev Cogn B Aging Neuropsychol Cogn. 2020 Jul;27(4):581-594. doi: 10.1080/13825585.2019.1653445. Epub 2019 Aug 14.
8
Spiny Projection Neuron Dynamics in Toxin and Transgenic Models of Parkinson's Disease.帕金森病毒素和转基因模型中的刺状突起神经元动力学。
Front Neural Circuits. 2019 Mar 15;13:17. doi: 10.3389/fncir.2019.00017. eCollection 2019.
9
Reduced striatal dopamine release during motor skill acquisition in Parkinson's disease.帕金森病患者在获得运动技能期间纹状体多巴胺释放减少。
PLoS One. 2018 May 30;13(5):e0196661. doi: 10.1371/journal.pone.0196661. eCollection 2018.
10
An adverse outcome pathway for parkinsonian motor deficits associated with mitochondrial complex I inhibition.与线粒体复合物 I 抑制相关的帕金森运动缺陷的不良结局途径。
Arch Toxicol. 2018 Jan;92(1):41-82. doi: 10.1007/s00204-017-2133-4. Epub 2017 Dec 5.